Xylem Inc. $XYL Shares Acquired by Hanson & Doremus Investment Management

Hanson & Doremus Investment Management increased its position in Xylem Inc. (NYSE:XYL) by 32.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,826 shares of the industrial products company’s stock after buying an additional 4,584 shares during the quarter. Hanson & Doremus Investment Management’s holdings in Xylem were worth $2,250,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XYL. Orion Porfolio Solutions LLC increased its stake in Xylem by 1.0% during the third quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after acquiring an additional 74 shares during the last quarter. Journey Strategic Wealth LLC lifted its stake in shares of Xylem by 1.5% in the 3rd quarter. Journey Strategic Wealth LLC now owns 5,107 shares of the industrial products company’s stock valued at $753,000 after purchasing an additional 77 shares in the last quarter. Quest Investment Management LLC grew its holdings in shares of Xylem by 1.0% during the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after purchasing an additional 77 shares during the period. Keel Point LLC increased its position in Xylem by 4.6% during the 3rd quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock worth $263,000 after purchasing an additional 79 shares in the last quarter. Finally, SWS Partners increased its position in Xylem by 1.1% during the 4th quarter. SWS Partners now owns 7,402 shares of the industrial products company’s stock worth $1,008,000 after purchasing an additional 82 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Up 0.3%

XYL opened at $111.77 on Tuesday. The stock has a market capitalization of $26.57 billion, a PE ratio of 27.80, a P/E/G ratio of 1.59 and a beta of 1.05. The firm’s fifty day moving average price is $114.17 and its 200 day moving average price is $126.01. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, research analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem declared that its board has approved a stock buyback plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to repurchase up to 4.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s payout ratio is currently 42.79%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on XYL shares. Oppenheimer reduced their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Finally, UBS Group upped their price target on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Xylem has an average rating of “Moderate Buy” and a consensus target price of $152.77.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.